JAGX

Jaguar Health, Inc. - Common Stock (JAGX)

About Jaguar Health, Inc. - Common Stock (JAGX)

Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. It operates through the Human Health and Animal Health segments. The Human Health segment is involved in manufacturing human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment includes commercializing prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.

Details

Daily high

$1.29

Daily low

$1.16

Price at open

$1.21

52 Week High

$33.25

52 Week Low

$1.00

Market cap

4.4M

Dividend yield

0.00%

Volume

108,485

Avg. volume

404,041

P/E ratio

-.04

Jaguar Health, Inc. - Common Stock News